Insiders Atara Biotherapeutics, Inc.

Equities

ATRA

US0465131078

Real-time Estimate Cboe BZX Other stock markets 17:10:17 10/05/2024 BST			5-day change	1st Jan Change
0.544 ^USD	-0.33%		-17.61%	+7.64%

05-09	Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q1 Revenue $27.4M	MT
04-01	Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eric Dobmeier Not to Stand for Re-Election as Member of Board of Directors of Atara Biotherapeutics, Inc	03-29	CI
Atara Biotherapeutics, Inc. Announces Termination of Manher (Aj) Joshi as Executive Vice President, Chief Medical Officer, Effective as of February 2, 2024	01-08	CI
Ipsen: appointment of an independent director	04/09/23	CF
Atara Biotherapeutics, Inc. Announces Resignation of Beth Seidenberg from the Board of Directors	05/06/23	CI
Atara Biotherapeutics, Inc. Announces Executive Changes	08/05/23	CI
Atara Biotherapeutics, Inc. Announces the Resignation of Utpal Koppikar as Executive Vice President	31/03/23	CI
Atara Biotherapeutics, Inc. Announces the Resignation of Utpal Koppikar as Chief Financial Officer	31/03/23	CI
Atara Biotherapeutics Announces Changes to Its Board of Directors	20/12/22	CI
Atara Biotherapeutics, Inc. Appoints Carol Gallagher as Chair of the Board of Directors	19/12/22	CI
Atara Biotherapeutics, Inc. to Terminate Kristin Yarema as Senior Vice President and Chief Commercial Officer, Effective as of November 15, 2022	08/08/22	CI
Insider Sell: Atara Biotherapeutics	29/06/22	MT
Atara Biotherapeutics Names Charlene Banard Chief Technical Officer	05/04/22	MT
Atara Biotherapeutics, Inc. Names Charlene Banard as Chief Technical Officer	05/04/22	CI
Insider Sell: Atara Biotherapeutics	17/11/21	MT
Insider Sell: Atara Biotherapeutics	05/11/21	MT
Insider Trends: 90-Days of Insider Buying at Atara Biotherapeutics Eased Back with Share Disposition	20/08/21	MT
Atara Biotherapeutics, Inc. Appoints Ameet Mallik to the Board of Directors	09/08/21	CI
Insider Trends: 90-Day Insider Buying Trend Reduced with Disposition of Atara Biotherapeutics Shares	29/06/21	MT
Insider Trends: Insider Buying Added to with Purchase of Atara Biotherapeutics Shares	15/06/21	MT
Insider Trends: 90-Days of Insider Buying at Atara Biotherapeutics Eased Back with Share Disposition	20/05/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Atara Biotherapeutics, Inc.

Equities

ATRA

US0465131078

Insiders

Filters